Gene expression markers of recurrence risk in cancer patients after chemotherapy

Details for Australian Patent Application No. 2008289148 (hide)

Owner Genomic Health, Inc. Aventis Inc.

Inventors Sparano, Joseph; Yoshizawa, Carl; Baker, Joffre; Gray, Robert; Shak, Steven

Agent FB Rice

Pub. Number AU-A-2008289148

PCT Pub. Number WO2009/026128

Priority 60/956,380 16.08.07 US; 60/970,490 06.09.07 US; 60/970,188 05.09.07 US

Filing date 15 August 2008

Wipo publication date 26 February 2009

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

25 February 2010 PCT application entered the National Phase

  PCT publication WO2009/026128 Priority application(s): WO2009/026128

23 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008289172-Metabolomic profiling of prostate cancer

2008289135-2-heteroarylamino-pyrimidine derivatives as kinase inhibitors